健康大视野·医学分册2023,Issue(6) :62-64.DOI:10.3969/j.issn.1005-0019.2023.06.024

金双歧联合思密达治疗婴幼儿腹泻的临床分析

李晓娟
健康大视野·医学分册2023,Issue(6) :62-64.DOI:10.3969/j.issn.1005-0019.2023.06.024

金双歧联合思密达治疗婴幼儿腹泻的临床分析

李晓娟1
扫码查看

作者信息

  • 1. 淄博市妇幼保健院儿科,山东 淄博 255000
  • 折叠

摘要

目的:探析金双歧联合思密达治疗婴幼儿腹泻的临床效果.方法:参选对象筛选自我院2019年10月-2021年10月收治的120例腹泻患儿,按照治疗方案的差异分为样本数值相同的两组,对照组行思密达治疗,实验组行金双歧联合思密达治疗,对比两组的临床效果.结果:实验组的临床指标、临床症状显著优于对照组(P < 0.05);两组的不良反应发生率、满意率经比较差异显著(P < 0.05).结论:金双歧联合思密达在婴幼儿腹泻治疗中达到了较为确切的效果,临床症状明显改善,降低了不良反应,提高了安全性和满意度,值得参考和采纳

Abstract

Objective To explore the clinical effect of golden bifid combined with smecta in the treatment of infantile diarrhea. Methods: 120 children with diarrhea treated in our hospital from October 2019 to October 2021 were selected and divided into two groups with the same sample value according to the difference of treatment schemes. The control group was treated with Smecta,and the experimental group was treated with golden bifid combined with Smecta. The clinical effects of the two groups were compared. Results: The clinical indexes and symptoms of the experimental group were significantly better than those of the control group (P<0.05). The incidence of adverse reactions and satisfaction rate between the two groups were significantly different (P<0.05). Conclusion: Golden Bifidobacterium combined with Smecta has achieved a definite effect in the treatment of infantile diarrhea,with obvious improvement of clinical symptoms,reduction of adverse reactions and improvement of safety and satisfaction,which is worthy of reference and adoption.

关键词

金双歧/思密达/婴幼儿腹泻/效果

Key words

golden bifid/Smecta/Infantile diarrhea/effect

引用本文复制引用

出版年

2023
健康大视野·医学分册
中国保健协会

健康大视野·医学分册

ISSN:1005-0019
参考文献量13
段落导航相关论文